4-CHLORO-1-(3-METHYLPYRIDIN-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 97.0%, 250mg

(2S)-Octahydro-1H-indole-2-carboxylic acid, 97%, 1g

N-Methyl-4-(trifluoromethoxy)aniline, 97.0%, 1g

(2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide, 97%, 1g

9-Julolidine boronic acid, 95.0%, 1g

2-(1-Cyclopentenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)1g

(3,5-Difluoropyridin-4-yl)methanamine, 98%, 250mg

(2E)-3-[4-(benzyloxy)phenyl]-1-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

Soluzione standard multielemento ICP CR-11, ROTI®Star, 250 ml, HDPE

2,5-Dimethyl-thiophene-3-carbaldehyde, 95.0%, 5g

3-Bromo-2,5-dimethylthiophene, 95%, 5g

ethyl (2Z)-2-chloro-2-[2-(2,5-dimethylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 10g

5-CHLORO-3-METHYL-4-AMINO-1H-PYRAZOLE, 95.0%, 5g